• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌 η -p-环戊二烯复合物与锌指蛋白 NCp7 的共价与非共价结合

Covalent versus Noncovalent Binding of Ruthenium η -p-Cymene Complexes to Zinc-Finger Protein NCp7.

机构信息

CAS Key Laboratory of Soft Matter Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, P.R. China.

Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, 230026, P.R. China.

出版信息

Chemistry. 2019 Oct 1;25(55):12789-12794. doi: 10.1002/chem.201902434. Epub 2019 Sep 9.

DOI:10.1002/chem.201902434
PMID:31385356
Abstract

Ruthenium-arene complexes are a unique class of organometallic compounds that have been shown to have prominent therapeutic potencies. Here, we have investigated the interactions of Ru-cymene complexes with a zinc-finger protein NCp7, aiming to understand the effects of various ligands on the reaction. Five different binding modes were observed on selected Ru-complexes. Ru-cymene complex can bind to proteins through either noncovalent binding alone or through a combination of covalent and noncovalent binding modes. Moreover, the noncovalent interaction can promote the coordination of Ru to NCp7, resulting synergistic effects of the different ligands. The binding of Ru(Cym) complexes leads to dysfunction of NCp7 through zinc-ejection and structural perturbation. These results indicate that the reactivity of Ru-complexes can be modulated by ligands through different approaches, which could be closely correlated to their different therapeutic effects.

摘要

钌芳烃配合物是一类独特的有机金属化合物,已被证明具有显著的治疗功效。在这里,我们研究了 Ru-柠檬烯配合物与锌指蛋白 NCp7 的相互作用,旨在了解不同配体对反应的影响。在选定的 Ru-配合物上观察到了五种不同的结合模式。Ru-柠檬烯配合物可以通过非共价键单独结合或通过共价和非共价键结合模式的组合与蛋白质结合。此外,非共价相互作用可以促进 Ru 与 NCp7 的配位,从而产生不同配体的协同效应。Ru(Cym) 配合物的结合导致 NCp7 通过锌喷射和结构扰动而功能失调。这些结果表明,配体可以通过不同的方法来调节 Ru-配合物的反应性,这可能与其不同的治疗效果密切相关。

相似文献

1
Covalent versus Noncovalent Binding of Ruthenium η -p-Cymene Complexes to Zinc-Finger Protein NCp7.钌 η -p-环戊二烯复合物与锌指蛋白 NCp7 的共价与非共价结合
Chemistry. 2019 Oct 1;25(55):12789-12794. doi: 10.1002/chem.201902434. Epub 2019 Sep 9.
2
Selective Targeting of the Zinc Finger Domain of HIV Nucleocapsid Protein NCp7 with Ruthenium Complexes.用钌配合物选择性靶向 HIV 核衣壳蛋白 NCp7 的锌指结构域。
Chemistry. 2018 Dec 20;24(72):19146-19151. doi: 10.1002/chem.201803917. Epub 2018 Nov 20.
3
Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.错配修复蛋白MutS与嵌入型钌(II)芳烃配合物的错配DNA加合物的结合。
J Biol Inorg Chem. 2008 Aug;13(6):993-9. doi: 10.1007/s00775-008-0386-3. Epub 2008 May 20.
4
The interactions of the ruthenium(II)-cymene complexes with lysozyme and cytochrome c.钌(II)-柠檬烯配合物与溶菌酶和细胞色素 c 的相互作用。
J Biol Inorg Chem. 2020 Mar;25(2):253-265. doi: 10.1007/s00775-020-01758-3. Epub 2020 Feb 4.
5
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.单功能有机金属钌(II)抗肿瘤复合物在无细胞培养基中的DNA相互作用
Biochemistry. 2003 Oct 7;42(39):11544-54. doi: 10.1021/bi034933u.
6
Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η-p-cymene)Cl(L)] complexes.新型[Ru(η-p-cymene)Cl(L)]配合物的合成、表征、与人血清白蛋白的相互作用及抗肿瘤活性。
J Inorg Biochem. 2020 Dec;213:111256. doi: 10.1016/j.jinorgbio.2020.111256. Epub 2020 Sep 15.
7
Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.鉴定钌芳基肽缀合物抗癌活性的结构决定因素。
Chemistry. 2013 Jul 8;19(28):9297-307. doi: 10.1002/chem.201300889. Epub 2013 May 27.
8
Chemotherapeutic Activities of New η--Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands.新型η-对异丙基苯钌(II)和锇(II)与螯合SS和三齿SNS配体配合物的化疗活性
Molecules. 2024 Feb 21;29(5):944. doi: 10.3390/molecules29050944.
9
Effects induced by η-p-cymene ruthenium(II) complexes on Langmuir monolayers mimicking cancer and healthy cell membranes do not correlate with their toxicity.η-对伞花烃钌(II)配合物对模拟癌细胞和健康细胞膜的 Langmuir 单层膜的诱导作用与其毒性不相关。
Biochim Biophys Acta Biomembr. 2024 Jun;1866(5):184332. doi: 10.1016/j.bbamem.2024.184332. Epub 2024 May 11.
10
Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.基于钌(II)芳烃配合物与2-芳基二唑配体的抗癌特性推导构效关系
Inorg Chem. 2014 Oct 20;53(20):11274-88. doi: 10.1021/ic501865h. Epub 2014 Oct 10.

引用本文的文献

1
Fine-tuning the cytotoxicity of ruthenium(II) arene compounds to enhance selectivity against breast cancers.微调钌(II)芳基配合物的细胞毒性,以提高对乳腺癌的选择性。
Dalton Trans. 2023 Aug 22;52(33):11679-11690. doi: 10.1039/d3dt02037a.
2
Dichloro Ru(II)--cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case Study.二氯钌(II)-异丙苯-1,3,5-三氮杂-7-磷杂金刚烷(RAPTA-C):一项案例研究。
ACS Pharmacol Transl Sci. 2023 Jun 22;6(7):982-996. doi: 10.1021/acsptsci.3c00085. eCollection 2023 Jul 14.
3
Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line.
钌配合物对AKR1C1、AKR1C2和AKR1C3酶表现出强效抑制作用,并对耐化疗的卵巢癌细胞系具有抗增殖作用。
Front Pharmacol. 2022 Aug 11;13:920379. doi: 10.3389/fphar.2022.920379. eCollection 2022.
4
Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected -Diketone, 8-Hydroxyquinoline and Pyrithione Ligands.特定β-二酮、8-羟基喹啉和吡啶硫酮配体的钌配合物的溶液化学性质与生物活性比较
Pharmaceuticals (Basel). 2021 May 27;14(6):518. doi: 10.3390/ph14060518.
5
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.含苯并稠合巯基吡啶的有机钌配合物克服卵巢癌细胞中的铂耐药性。
Cancers (Basel). 2021 May 20;13(10):2493. doi: 10.3390/cancers13102493.
6
Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE.有机钌(II)配合物中吡硫翁配体的结构异构和增强的亲脂性增加了对 AChE 和 BuChE 的抑制作用。
Int J Mol Sci. 2020 Aug 6;21(16):5628. doi: 10.3390/ijms21165628.
7
Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS.高效液相色谱-电感耦合等离子体质谱法研究顺铂类化疗候选药物与人血清蛋白的结合动力学。
Molecules. 2020 Mar 26;25(7):1512. doi: 10.3390/molecules25071512.
8
Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity.芳基金属硝呋太尔衍生物通过抑制组织蛋白酶 B 的活性抑制肿瘤细胞侵袭。
Inorg Chem. 2019 Sep 16;58(18):12334-12347. doi: 10.1021/acs.inorgchem.9b01882. Epub 2019 Aug 29.